Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
1,710,580
-
Shares change
-
+185,430
-
Total reported value, excl. options
-
$24,258,264
-
Value change
-
+$2,579,198
-
Number of buys
-
14
-
Number of sells
-
-13
-
Price
-
$14.13
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q1 2018
38 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q1 2018.
IRADIMED CORP - Common Stock (IRMD) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,710,580 shares
of 12,733,410 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (470,382 shares), VANGUARD GROUP INC (194,477 shares), Ranger Investment Management, L.P. (128,050 shares), CADENCE CAPITAL MANAGEMENT LLC (112,529 shares), Boston Partners (74,458 shares), Menta Capital LLC (66,476 shares), Russell Investments Group, Ltd. (59,118 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (55,900 shares), RENAISSANCE TECHNOLOGIES LLC (53,458 shares), and Eversept Partners, LP (51,059 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.